Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells-Reference-Cited by-同舟云学术

Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells

Published:1992-12 Issue:2 Volume:203 Page:456-465
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Ono Mayumi,Nakayama Yoshifumi,Princler Gerald,Gopas Jacob,Kung Hsiang-Fu,Kuwano Michihiko

Publisher

Elsevier BV

Subject

Cell Biology

Reference60 articles.

1. Epidermal Growth Factor

2. Allosteric regulation of the epidermal growth factor receptor kinase.

3. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.

4. Selective phospholipase C activation

5. Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation;Molecular Cancer Therapeutics;2004-04-01

2. Regulation of the epidermal growth factor receptor in fetal rat lung fibroblasts during late gestation;ENDOCRINOLOGY;1998

3. Regulation of the Epidermal Growth Factor Receptor in Fetal Rat Lung Fibroblasts during Late Gestation*;Endocrinology;1998-04-01

4. Heparin-binding Epidermal Growth Factor-like Growth Factor: p91 Activation, Induction of Plasminogen Activator/Plasminogen Activator Inhibitor, and Tubular Morphogenesis in Human Microvascular Endothelial Cells;Japanese Journal of Cancer Research;1996-01

5. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines;British Journal of Cancer;1995-05